
Life Sciences · Commercialisation
Connecting UK life sciences with Asian markets — exploring commercialisation, partnerships and market-entry pathways.
About
Scientific innovation creates possibilities. Turning those possibilities into commercial opportunities requires market understanding, the right relationships and a clear strategy.
Vagelos Partners works at the intersection of life science innovation and international business development, helping companies explore new markets, identify potential partners and develop pathways towards commercialisation across Asia.
Our focus is on connecting promising technologies with relevant markets, commercial relationships and actionable opportunities.
What We Do
We support life science companies exploring international growth through focused commercial research, partnership development and market-entry support.
We help life science companies explore new markets and understand the commercial opportunities available to them.
The right partnerships can open doors to new markets, capabilities and customers. We help identify potential commercial partners and develop relationships aligned with each company's objectives.
We help companies explore opportunities to commercialise their technologies through cross-border business relationships.
Successful international expansion starts with understanding the market. We provide focused commercial research to help companies evaluate opportunities before committing resources.
Engagements are tailored to the project and undertaken within applicable legal and regulatory requirements.
Markets
We focus on selected Asian markets where international collaboration can create commercial opportunities for life science innovators.
Explore potential licensing, distribution and strategic collaboration opportunities within Japan's life science and healthcare ecosystem.
Explore regional business development, strategic partnerships and connections with the wider Southeast Asian ecosystem.
Explore cross-border commercial relationships, distribution opportunities and potential market-development pathways.
Identify potential industry partners and explore commercial opportunities within Taiwan's biotechnology, medical technology and healthcare innovation ecosystem.
Explore strategic partnerships and market opportunities within South Korea's biotechnology, medical technology and healthcare sectors.
Assess selected markets and identify potential local partners to support regional expansion.
Our geographic approach is selective and market-specific. Each engagement is shaped by the company's objectives, technology, commercial readiness and target markets.
Our Approach
Every company and technology has different commercial needs. Our approach begins with understanding the opportunity and identifying practical next steps.
Discover
Understand the technology, business objectives and commercial ambitions. Establish priorities and identify the questions that need to be answered.
Assess
Evaluate potential markets, commercial pathways and partnership opportunities through focused research and structured assessment.
Connect
Identify relevant commercial partners and support targeted outreach and introductions where there is a clear strategic fit.
Develop
Support the progression of promising opportunities towards commercial agreements and market entry, according to the agreed scope of work.
Our objective is to help companies move from market exploration to actionable commercial opportunities.
Who We Work With
Therapeutics, platform technologies and research-led innovations.
Medical devices, diagnostics and technologies designed to address clinical needs.
Technology-enabled approaches to life science research and development.
Digital health solutions and technologies addressing healthcare needs.
University-originated companies exploring their first international commercial opportunities.
We work with companies at different stages of development, from early market exploration to businesses preparing for international expansion.
Our Belief
Innovation does not create commercial success on its own.
Understanding market needs, identifying the right partners and developing sustainable business relationships are essential steps in bringing new technologies to market.
At Vagelos Partners, we believe international commercialisation should be purposeful, relationship-driven and grounded in a clear understanding of each company's objectives.
We focus on identifying opportunities where the right connections and commercial strategy can help promising innovations reach wider markets.
Contact
Are you a UK or European life science company exploring opportunities in Asia?
Whether you are assessing a new market, looking for a licensing partner or considering international expansion, we welcome conversations about potential collaboration.
Tell us about your company, your technology and the markets you are considering — we will come back to you directly.